Vitamin D as an early predictor of multiple sclerosis activity and progression.
about
Update in vitamin D and multiple sclerosisNutrition facts in multiple sclerosisEstimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/LEnvironmental factors in autoimmune diseases and their role in multiple sclerosisVitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseVitamin D and immunityVitamin D-binding protein levels do not influence the effect of vitamin D repletion on serum PTH and calcium: data from a randomized, controlled trialEnvironmental factors and multiple sclerosis severity: a descriptive study.How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.Molecular mechanism underlying the impact of vitamin D on disease activity of MS.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Low vitamin D levels predict clinical features of schizophrenia.Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis riskIncreased circulating levels of vitamin D binding protein in MS patients.Clinical trials in progressive multiple sclerosis: lessons learned and future perspectivesInterferon beta and vitamin D synergize to induce immunoregulatory receptors on peripheral blood monocytes of multiple sclerosis patients.CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesThe Association of Vitamin D Receptor Polymorphisms with Multiple Sclerosis in a Case-Control Study from KuwaitFactors Affecting 25-Hydroxyvitamin D Concentration in Response to Vitamin D Supplementation.Environmental effects of ozone depletion and its interactions with climate change: progress report, 2015.Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases SusceptibilityFarming, Foreign Holidays, and Vitamin D in OrkneyVitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up.Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.Effect of vitamin D on MS activity by disease-modifying therapy class.Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosisRetinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelinationDoes environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot studyLong-term evolution of multiple sclerosis disability in the treatment era.Association of vitamin D status and clinical and radiological outcomes in a treated MS population in Poland.Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism.Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients.Osteoporosis and multiple sclerosis: risk factors, pathophysiology, and therapeutic interventions.Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.Modifiable environmental factors in multiple sclerosis.Computational modeling of brain pathologies: the case of multiple sclerosis.Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis.Identification of the miRNA-mRNA regulatory network in multiple sclerosis.
P2860
Q26780466-69E100A5-7427-40DA-9D5E-6FBD9C17E9A3Q26851247-709DAD79-257D-44E6-8B24-1C53E1080C62Q28069109-145FB72C-F11E-46A2-AE43-818D8F6C331AQ28078461-3660674E-B70B-4ED5-940B-4BEB368BF129Q28081150-D3FF8D2E-17AF-46F4-BED1-02DC549C93F5Q28087758-839D226A-E706-4804-9F05-1C61F737E616Q30796481-09EE3C74-C943-405D-9FB3-FECB6A1E9FA4Q33834066-581297EA-122F-4433-891A-7307D16E34CAQ33988240-ACCDD733-19A6-463C-8338-3A5BB80021D8Q34268651-D655629A-4C2E-4BDD-8CC1-F563A4C1B062Q34468304-D90A9984-8E68-4084-A008-07CB3DB5C6D8Q34616344-1E3D311B-05D8-40AD-A1B8-BA2F6561CBE6Q34678847-2A0745AF-83E8-47EA-ADB4-BE6A90DB4425Q35003669-6438AACA-7B03-4795-96DD-839B47A99FA0Q35182733-787597B7-A285-46F1-A29A-C390AAF8714FQ35536405-B95737AF-A33A-4926-883B-7369CA44CD0BQ35571261-5431D155-B450-4A62-818B-100699B2F037Q35833405-B5911408-9676-46F5-8B6B-9FBF11AB2C80Q35894937-4BBE0FF9-C426-4BE7-825C-54C62DF895F3Q35907709-17134FC5-9499-4EBE-9B89-E62283F70037Q35922211-4BD6F37C-9F20-4CC2-949E-C5DC4F221BC7Q36019979-87A6907F-AFFA-4CBD-9713-CEB75F2A2F09Q36045080-45DB00BF-C9E6-492E-A6CF-FC584D9D87BEQ36061629-B318C202-A9AC-462B-8D11-481D7E7EF611Q36242310-041981FE-2182-48DF-A4C1-0EEAD3FDBCCFQ36314027-09000F72-7088-450C-82E8-66220602166BQ36326855-A9DED20E-81DB-4A00-B89F-E941AE8CBE89Q36344854-C8D86FDC-5115-4A20-B3D6-396D2013AD20Q36848315-3281B844-951D-4B72-95A6-310111BAA5BDQ37107063-EE128F28-9379-422B-8D6D-5D32F55BF03FQ37409279-141498D9-8838-41A8-8D54-EE05BE6D2235Q37653508-726FCB4A-361B-4539-9D56-2658A7CE43B2Q37721243-21E17B1A-CA7A-43AF-BBC4-FE0BB254010FQ37736791-0EC6280D-C383-475C-ACC6-DE390D43735AQ38215692-B5E39930-1C96-4479-AAF0-B1B4E4203756Q38265170-961FE7C1-5338-4960-8886-BFB583ABDE37Q38269727-BD9BF75B-530F-4693-97F7-8B300DD46272Q38383159-EC06369A-5832-40D1-9E3B-27A0B7B3B360Q38387302-BCE47753-428C-4AF2-A9E5-8F228FE21A1CQ38440761-630F4F61-1E76-466E-8085-A933554804AE
P2860
Vitamin D as an early predictor of multiple sclerosis activity and progression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vitamin D as an early predictor of multiple sclerosis activity and progression.
@en
Vitamin D as an early predictor of multiple sclerosis activity and progression.
@nl
type
label
Vitamin D as an early predictor of multiple sclerosis activity and progression.
@en
Vitamin D as an early predictor of multiple sclerosis activity and progression.
@nl
prefLabel
Vitamin D as an early predictor of multiple sclerosis activity and progression.
@en
Vitamin D as an early predictor of multiple sclerosis activity and progression.
@nl
P2093
P2860
P50
P921
P1433
P1476
Vitamin D as an early predictor of multiple sclerosis activity and progression.
@en
P2093
Chris H Polman
Christoph Pohl
David H Miller
Dirk Pleimes
Ernst-Wilhelm Radü
Gilles Edan
Kassandra L Munger
Kelly Claire Simon
Mark S Freedman
Rick White
P2860
P304
P356
10.1001/JAMANEUROL.2013.5993
P407
P577
2014-03-01T00:00:00Z